The selective vulnerability of a particular subset of neurons is a common feature of neurodegenerative diseases such as Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Parkinson's disease is mainly characterized by the degeneration of the nigrostriatal dopaminergic neurons. Numerous data suggest an involvement of the energetic metabolism in the selective vulnerability of these cells. Widespread mitochondrial abnormalities have indeed been described in Parkinsonian patients, suggesting that this disease could be due to some alterations of oxidative phosphorylation (for review, see Di Mauro, 1993) . Moreover, the nigrostriatal dopaminergic neurons are selectively destroyed in mouse (Heikkila et al., 1984) , monkey (Langston et al., 1984) , and human following the systemic administration of I-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), an inhibitor of the complex I of the respiratory chain, which is less toxic toward the other catecholaminergic neurons in spite of their ability to accumulate it. Similarly, the local injection of rotenone, an inhibitor of the complex I of the respiratory chain, into the median forebrain bundle greatly diminished the striatal content of dopamine without affecting that of GABA (Heikkila et al., 1985) . This latter result suggests that rotenone is more toxic for the nigrostriatal dopaminergic neurons than for the striatonigral GABAergic neurons. Previously, we have proposed that a metabolic weakness of the dopaminergic neurons could account for their particular vulnerability to impairment of energetic metabolism (Marey-Semper et al., 1993) . In order to substantiate this hypothesis, we had compared, as an index of the energetic metabolism, the inhibitory effects of rotenone on the high-affinity uptake of different neurotransmitters in mouse striatal synaptosomes or cultured mesencephalic neurons. In both preparations, the uptake of dopamine was much more affected than that of other neurotransmitters, suggesting indeed that intrinsic metabolic properties of the dopaminergic neurons could explain their natural vulnerability (Marey-Semper et al., 1993) .
In the present study, to further assess the existence of a greater vulnerability of dopaminergic neurons to an energetic stress, we have compared the sensitivity of cultured murine mesencephalic neurons to the neurotoxic effects of rotenone. Since neuronal vulnerability following a metabolic impairment appears to be related to glutamate receptor activation (Novelli et al., 1987; Zeevalk et al., 199 1, 1995) we also investigated the toxic effects of this excitatory amino acid.
Cultured dopaminergic neurons were found to be only slightly more sensitive than GABAergic neurons to the toxic effects of either rotenone or glutamate. However, these compounds, when used together, were surprisingly much more toxic for dopaminergic neurons than for GABAergic neurons.
Materials and Methods
Biochemicals reagents. All biochemical reagents were purchased from Sigma except when indicated. Neurotransmitter uptake measurements in cultured neurons. Dissociated mesencephalic neurons from 14.d-old Swiss mouse embryos were prepared as previously described (Chamak and Prochiantz, 1989) with <he followingmodific~tions.
Culture dishes were incubated at 37°C for 3 hr in Dulbecco's modified Eagle's medium (DMEM) (Gibco) SUDplemented with 10% (v/v) fetal calfuserum. Wells were wailed and ceils were plated at a density of 0.25 IO6 per cm* in 24. or 96-well plates in DMEM medium supplemented with D-glucose (33 mM) (Merck), L-glutamine (2 mM) (Gibco), NaHCO, (3 mM) (Merck), HEPES (5 mM, pH 7.4) (Gibco), 0.1% ovalbumin (w/v), insulin (25 p,g/ml), iron-free transfenin (100 kg/ml), progesterone (20 nM), putrescin (60 FM), and selenium salt (30 nM). After 5 d, the culture medium was replaced by fresh medium containing either rotenone dissolved in DMSO or DMSO alone (l/200, v/v) . After a 6 hr incubation period, L-glutamic acid (100 pM final concentration), AMPA (100 FM, Tocris Neuramin), or NMDA (200 &M) was added for I hr. (+)MKEOl (1 FM) was added 5 min prior to glutamate agonists, whereas D(-)APV (500 PM, Research Biochemical International) and DNQX (50 FM, Research Biochemical International) were added at the same time as the glutamate agonists. In some experiments (see Table 3 , Fig. 3 ), cells were washed once with Krebs bicarbonate buffer (124 mM NaCl or 124 mM choline chloride, 35 mM KCI, 1.25 mM K,HPO,, 26.3 mM NaHCO,, 1.2 mM CaCl,, 10 mM glucose) and incubated for 1 hr in the same buffer with or without M&O, (1.2 rnMj. AMPA (100 EM). NMDA (200 IJ,M). and tetrodotoxin (T?X)-('I PM). in all cases, ceils were washkd &iceand further incubated in fresh DMEM medium for 16-17 hr.
After this 16-17 hr incubation period, cells were placed on ice, washed once with cold phosphate-buffered saline, pH 7.4, containing glucose (5 mM) and Ca *+-Mg*+ (PBS-glucose). Uptake measurements were performed by incubating neurons at 37°C for 15 min in PBSglucose supplemented with: dopamine (DA) uptake (1 mM ascorbic acid, 30 nM DA, 0.9 pCi/ml); GABA uptake (10 p,~ GABA, 2.5 pCi/ ml); serotonin (5.HT) uptake (100 nM 5-HT, 1 &i/ml); choline uptake [40 nM choline, 3.25 &i/ml ('H-DA 36 Ci/mmol NEN, and 'H-GABA 94 Ci/mmol, 3H-5-HT 10.4 Ci/mmol, 'H-choline 81 Ci/mmol, Amersham)]. For GABA uptake, incubation medium was supplemented with p-alanine (500 FM) to prevent astrocytic GABA uptake (Schousboe et al., 1979) . The reaction was stopped by placing cells on ice and by two washes with ice-cold PBS-glucose. Neurons were lysed with a 1% sodium dodecyl sulfate (SDS) solution (w/v) and radioactivity was measured by liquid scintillation counting. Nonspecific uptake values were determined in the presence of benztropine (1 FM, Merck), nipecotic acid (500 FM), or imipramine (1 JLM), which are specific inhibitors of DA, GABA, and 5-HT uptakes, respectively (Coyle et al., 1969; Javai'd et al., 1979; Schousboe et al., 1979) . For choline, nonspecific uptake was measured at 0°C. The mean of nonspecific uptake values was subtracted from each determination. Results are expressed in percent of control values obtained in the absence of rotenone and glutamate. Each determination was carried out in either triplicate or q;adruplicate.
Differential toxic& ratio (DTR) value. In order to auantifv the degree of selectivity toward' dopaminerg'ic neurons of the tdxicity-induced on cultured mesencephalic neurons by various treatments, we used the following ratio:
(GABA uptake, % of control) -(DA uptake, % of control) (GABA uptake, % of control) defined as the differential toxicity ratio (DTR). Assay of cell suwival. Cell survival was estimated with the 3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide (Mm, Merck)-based colorime& assay (Denizot and Lang, 1986) . Briefly, cells were incubated for 3 hr at 37°C in the nresence of M'IT (0.5 me/ml) dissolved in fresh DMEM medium. The incubation medium was re$a&d by DMSO and the absorption at 570 nm was measured. Results were expressed in percent of control values obtained in the absence of rotenone and glutamate.
Anti-tyrosine hydroxylase immunocytochemistry. Cells were fixed with 4% PBS-formaldehyde for 20 min at room temperature. After two washes with PBS containing bovine serum albumin 5% (w/v) and tween 0.1% (v/v) (PBS-BSA-T), cells were incubated for 2 hr with mouse monoclonal anti-tyrosine hydroxylase antibody (40 kg/ml, Boehringer) diluted 25.fold in PBS-BSA-T at room temperature. Cells were then washed twice with PBS-BSA-T and incubated for 1 hr with peroxidasecoupled goat anti-mouse IgG (1 mg/ml, BioSys) diluted IOO-fold in PBS-BSA-T After two washes with PBS-BSA-T, cells were rinsed with Tris (100 mM, pH 7.5). Peroxidase activity was revealed by incubation with 3-3'.diaminobenzidine [0.04% (w/v)] and H,O, diluted [0.02% (v/ v)] in Tris (100 mM pH 7.5) for 6-8 min. The reaction was stopped by rinsing wells with water. The number of stained neurons bearing at least one neurite was determined in each well by counting 24 microscopic fields covering 5.3% of the well surface. Results are expressed in percent of control values obtained in the absence of rotenone and glutamate.
Results
Effects of rotenone und glutamate on mesencephalic dopaminergic and GABAergic neurons In order to establish whether dopaminergic neurons displayed a greater vulnerability than GABAergic neurons to metabolic stress, the toxic effect of rotenone on cultured mesencephalic neurons from 14-d-old mouse embryos was analyzed. Rotenone was chosen as a metabolic inhibitor of the complex I of the respiratory chain (Ernster et al., 1963) because its lipophilic character suggests that it can penetrate into all neuronal types with equivalent efficiency. The delayed toxicity induced by a 6 hr rotenone exposure on mesencephalic dopaminergic and GABAergic neurons was estimated by measuring, after a 16 hr recovery period, the residual high-affinity uptakes of DA and GABA used as indices of viability of the dopaminergic and GABAergic (Radian et al., 1990) neurons.
Rotenone concentrations lower than 0.5 nM did not induce any decrease in neurotransmitter uptake, whereas both uptake values reached background levels for rotenone concentrations higher than 10 nM (data not shown). The application of 5 nM rotenone resulted in a residual specific uptake of 43 + 3% for DA and 48.5 t 3% for GABA (Fig. lA) , suggesting that rotenone does not exert a selective neurotoxicity on dopaminergic neurons.
Mesencephalic dopaminergic and GABAergic neurons were then exposed for 6 hr to various concentrations of rotenone and for 1 hr to 100 pM glutamate, the neurotoxicity of these treatments being estimated as before following a 16 hr recovery period. Dopaminergic neurons were found to be three times more vulnerable than GABAergic neurons to the prolonged exposure to 5 nM rotenone followed by the 1 hr application of 100 FM glutamate (Fig. 2) . This higher vulnerability of the dopaminergic neurons resulting from the synergistic effects of rotenone (5 nM) and glutamate (100 FM) was further indicated by the calculation of a differential toxicity ratio (DTR) as described in Materials and Methods. A DTR value of 0 indicates that mesencephalic dopaminergic and GABAergic neurons are similarly destroyed, whereas a value of 1 reveals that the treatment destroys all dopaminergic neurons but only partially destroys the GABAergic neurons. Indeed, the combined exposure of the cells to rotenone (5 nM) and glutamate (100 p,M) led to a DTR of 0.63, while DTR values of 0.11 and 0.13 were found when both populations were exposed, respectively, to rotenone or glutamate alone (Fig.  lA, Table 1) .
Complementary experiments were performed in order to ensure that the estimations of the residual uptakes of 3H-DA and 3H-GABA were reliable indices of survival of the dopaminergic and GABAergic neurons, respectively. For this purpose, the by the synergistic effects of glutamate and an impairment of the energetic metabolism. Mesencephalic neuronal cultures were exposed to 5 nM rotenone (ROT) for 6 hr, or to 100 FM glutamate (GLU) for 1 hr, or to 5 nivt rotenone for 6 hr followed by 100 FM glutamate for 1 hr. A, After a 16 hr recovery period, toxicity toward dopaminergic and GABAergic neurons was determined by measuring their residual specific neurotransmitter uptake. Nonspecific uptake values were determined in the presence of 500 FM nipecotic acid or 1 PM benztropine. Data are expressed as percentages of control values. Each value is the mean 1. SEM of data obtained from three to nine independent experiments performed in triplicate or quadruplicate. B, After a 16 hr recovery period, the survival of the whole mesencephalic neuronal preparation and of the dopaminergic neurons were estimated using the methylthiazolyl tetrazolium-based calorimetric assay (MTT) and TH-immunolabeled cell counting, respectively. Data are expressed in percentages of control values. Each value is the mean 2 SEM of four independent experiments performed in quadruplicate. *p < 0.001 (Student's t test).
MTT test (Denizot and Lang, 1986) and immunocytochemistry with an anti-tyrosine hydroxylase antibody were used. The MTT test reflects the overall viability of the culture, containing mainly GABAergic neurons, while immunocytochemistry for tyrosine hydroxylase allows the evaluation of the number of dopaminergic neurons. Confirming the results obtained by measuring the residual uptakes of 3H-DA and 3H-GABA, the data provided by the MTT test and the anti-tyrosine hydroxylase immunocytochemistry further indicated that the dopaminergic neurons were much more vulnerable (90% destruction) than the total neuronal population (mainly GABAergic neurons) (56% destruction) to the sequential exposure to rotenone and glutamate (Fig. 1B) . Still in good agreement with results of specific uptake Figure 2. Selective toxic effect of glutamate on mesencephalic neurons pretreated with various concentrations of rotenone. Mesencephalic neuronal cultures were exposed to various concentrations of rotenone (ROT) for 6 hr followed by 100 FM glutamate (GUY) for 1 hr. After a 16 hr recovery period, toxicity toward dopaminergic (0) and GABAergic neurons (m) was determined by measuring the residual specific uptake of dopamine and GABA. Nonspecific uptake values were determined in the presence of 500 p,M nipecotic acid or 1 FM benztropine. The DTR value (see Materials and Methods) reached a peak for 5 nM rotenone. Each value is the mean 5 SEM of three independent experiments performed in quadruplicate.
measurements, no marked differential toxic effect was observed with either 5 nM rotenone or 100 FM glutamate alone (Fig. 1B) .
Effects of rotenone and glutamate on mesencephalic serotoninergic and striatal cholinergic and GABAergic neurons The toxic effects of glutamate (100 FM) and rotenone (5 nM), alone or in combination, were also investigated on mesencephalic serotoninergic neurons and on striatal cholinergic and GABAergic neurons by measuring the residual specific uptake of "H-5-HT, "H-choline, and 3H-GABA, respectively. The exposure of cells to either rotenone or glutamate affected to a similar extent these different neuronal populations, the neurotoxic effect of rotenone being more pronounced than that of glutamate in agreement with results obtained on mesencephalic GABAergic and dopaminergic neurons (Fig. lA, Table 2 ). However, following sequential exposure to rotenone and glutamate, the residual "H-5-HT uptake was particularly low (13.1 t 3% of control) when compared to that of 3H-GABA in mesencephalic and striatal cultures (33.6 t 4.5% and 30 -+ 3%, respectively), indicating the existence of a high vulnerability of serotoninergic neurons to this combined treatment, as observed for mesencephalic dopaminergic neurons. The cholinergic interneurons were even less affected than the GABAergic neurons since the residual uptake of "H-choline in striatal cultures was identical after exposure to rotenone alone or to the sequential application of rotenone and glutamate ( Table 2 ).
The selective toxicity toward dopaminergic neurons induced by rotenone and glutamate involves the activation of both NMDA and AMPA receptors Toxicity experiments were performed in the presence of either the specific antagonists or agonists of the ionotropic glutamate (25) 59.9 2 5.9 (9) 69 5 1.8 (9) 11.3 2 1.6 (33) 30.4 5 2.2 (33) 36.7 2 4.2 (7) 51.3 i 5.5 (6) 21.9 5 3 (9) 47 5 3 (9) 8.6 +-1. 4 (19) 26.7 ? 2.7 (19) 32.1 2 6.4 (7) 38.5 -c 9.6 (7) 31 -c 2.3 (13) 42.3 i 3.7 (13) 28.1 k 3.2 (11) 27 k 1.7 (11) 37.4 i 7.3 (12) 43.5 k 9 The addition of 1 FM MK801 and 500 pM APV, specific antagonists of the glutamate NMDA receptor, or 50 PM DNQX, a specific AMPA receptor antagonist, 5 min prior to the treatment with glutamate strongly decreased the DTR value (see Materials and Methods).
The combined exposure to 200 (IM NMDA and 100 F*M AMPA resulted in a DTR value equivalent to that obtained in the presence of glutamate. Data are expressed in percentages of control values. Number of specific neurotransmitter uptake measurements is indicated in brackets. *p < 0.001; DTR value is significantly different from that obtained with rotenone alone (Student's t test). In the table, the SEM of DTR values were omitted for simplicity. **p < 0.001; DTR value is significantly different from that obtained in the presence of rotenone and glutamate (Student's t test).
receptors in order to identify the glutamate receptor type involved in the selective toxicity of glutamate-on rotenone-pretreated dopaminergic neurons. Antagonists were added 5 min prior to the glutamate treatment while agonists were applied for 1 hr (as for glutamate) after the 6 hr exposure to rotenone. Results were expressed using the DTR index as previously described.
As shown in Table 1 , AMPA and NMDA receptor antagonists reduced the toxicity induced by glutamate on rotenone-pretreated dopaminergic neurons. Indeed, at the single concentration used, not only DNQX (50 FM), the AMPA antagonist, but also APV (500 FM) or MK80 1 (1 PM), the competitive and noncompetitive NMDA antagonists, had a much higher protective effect on dopaminergic neurons than on GABAergic neurons toward the toxic action of glutamate. In all cases the DTR value was markedly decreased when compared to that found in the absence of the antagonist (0.63) ( Table 1) . AMPA alone had a surprising preferential toxicity on rotenone-pretreated dopaminergic neurons since the DTR value (0.53) was only slightly lower than that found with glutamate (0.63). This was due to the presence of contaminating glutamate in the culture medium (Driscoll et al., 1993 ; I. Marey-Sempel, M. Gelman, and M. L&i-Strauss, unpublished observations), since MK801 markedly reduced this preferential toxicity of AMPA toward dopaminergic neurons (DTR of 0.14). As expected, due to the Mg*+ block, NMDA alone (200 PM) had little neurotoxic effect on rotenone-pretreated neurons (Table 1) . When the Mg2+ block of NMDA receptors was eliminated by the combined application of AMPA or by the removal of Mg2+ ions during the NMDA application, NMDA induced a particularly pronounced differential toxic effect on dopaminergic neurons (Table 3) . Indeed, in both cases the DTR values were particularly elevated (0.68 and 0.79, respectively) in the range of that found with glutamate (0.63) (Tables 1,3 ).
NMDA-selective neurotoxicity on rotenone-pretreated dopaminergic neurons depends critically on the presence of an extracellular physiological sodium concentration Using mouse mesencephalic slices, Johnson et al. (1992) have reported that the NMDA-induced burst firing of dopaminergic neurons depends exclusively upon sodium influx through NMDA-gated channels. The influx of this cation could therefore be involved in the high vulnerability to NMDA receptor stim- ROT + GLU 33.6 k 4.5* (69%) 13.1 z 3" (39%) 30 2 3* (86%) 42.7 + 2.6 (108%) Mesencephalic or striatal neuronal cultures were exposed to 5 nM rotenone (ROT) for 6 hr, to 100 PM glutamate for 1 hr (GLU), or to 5 nM rotenone for 6 hr followed by 100 FLM glutamate for I hr (ROT + GLU). The sequential exposure to rotenone and glutamate resulted in a strong selective toxic effect on mesencephalic serotoninergic neurons, whereas striatal GABAergic neurons and striatal cholinergic neurons displayed toxicity levels close to the one observed for mesencephalic GABAergic neurons. Data are expressed in percentages of control values. Each value is the mean ? SEM of three independent experiments performed in quadruplicate. In brackets, the neurotransmitter uptake value observed in the presence of glutamate and rotenone is expressed in percent of value obtained with rotenone alone. *p < 0.001; the residual specific uptake measured in the presence of glutamate and rotenone is significantly different from that obtained in the presence of rotenone alone (Student's f test). ulation displayed by the rotenone-pretreated dopaminergic neurons. When the extracellular sodium concentration was reduced from 150.3 mM to 26.3 mM, using choline chloride in place of sodium chloride, the selective toxic effect toward dopaminergic neurons was strongly reduced (DTR of 0.79 in the presence of sodium vs DTR of 0.30 in the presence of choline) ( . Selective toxicity of NMDA toward dopaminergic neurons in rotenone-pretreated mesencephalic preparation depends critically on extracellular sodium concentration. After a 6 hr incubation period with 5 nM rotenone (ROT), mesencephalic neuronal cultures were incubated in a Krebs bicarbonate buffer to which 200 FM NMDA was added or not. When sodium chloride was reduced from 150.3 mM (left) to 26.3 mM (right), using choline chloride in place of sodium chloride, selective NMDA toxicity on dopaminergic neurons was no longer observed. Data are expressed in percentages of control values. Each value is the mean -C SEM of data obtained from two to five experiments performed in quadruplicate. *p < 0.0001 (Student's t test); specific dopamine uptake was significantly different from GABA-specific uptake. sodium replacement, it was not blocked by the addition of 1 FM TTX.
Discussion
The strong synergistic effects of rotenone and glutamate, which when used together much more efficiently destroy dopaminergic neurons than GABAergic neurons, stand in sharp contrast to the lack of selectivity toward dopaminergic neurons of the toxicity induced by either of these two compounds. Interestingly, a lack of selectivity toward dopaminergic neurons of the neurotoxicity induced by various concentrations of glutamate has also been reported by Kikuchi and Kim (1993) , who have sought such a differential toxicity in order to investigate the role of excitatory amino acids in the death of dopaminergic neurons. The lack of selectivity toward dopaminergic neurons of the neurotoxicity induced by rotenone contrasts with our previous results demonstrating a particularly high sensitivity to rotenone of the specific uptake process of DA (Marey-Semper et al., 1993) . This discrepancy can be explained not only by variations in the concentrations of rotenone and incubation time (10 FM, 60 min in sensitivity measurements vs 5 nM, 360 min in toxicity measurements), but also by the presence or absence of glutamate in the culture medium used in the sensitivity or toxicity experiments, respectively. In order to rule out the hypothesis of a particular resistance of mesencephalic GABAergic neurons to the synergistic actions of rotenone and glutamate, the vulnerability of other neuronal types was also investigated. Striatal cholinergic and GABAergic neurons were, in fact, found to display the same weak vulnerability to the combined treatment with rotenone and glutamate as the mesencephalic GABAergic neurons. One should note that the striatal cholinergic neurons were found to be even more resistant to neurotoxicity than the striatal GABAergic neurons, as previously shown in many different systems (Davies and Beardsall, 1992; Henshaw et al., 1994) . Interestingly, the high sensitivity of serotoninergic mesencephalic neurons to the combined action of these compounds can be related to the natural vulnerability of these neurons, which are also affected in the course of Parkinson's disease (Scatton et al., 1983) . Although the degeneration of nigrostriatal dopaminergic neurons is the main physiopathological feature of Parkinson's disease, other neuronal types are also destroyed. Parkinson's disease indeed appears to affect ascending noradrenergic, cholinergic, and serotoninergic neurons whose cell bodies are also located in the mesencephalon. Unfortunately, we were unable to test the vulnerability of
